Reanalysis of a trial used to approve a commonly used injectable cholesterol lowering drug confirms the original analysis by accident
The “open data” movement runs aground on FOURIER
The “open data” movement runs aground on…
The “open data” movement runs aground on FOURIER
Reanalysis of a trial used to approve a commonly used injectable cholesterol lowering drug confirms the original analysis by accident